As of 2025-06-29, the EV/EBITDA ratio of Genscript Biotech Corp (1548.HK) is -736.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 1548.HK's latest enterprise value is 23,487.95 mil HKD. 1548.HK's TTM EBITDA according to its financial statements is -31.90 mil HKD. Dividing these 2 quantities gives us the above 1548.HK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 24.1x | 20.2x |
| Forward P/E multiples | 10.5x - 14.0x | 11.0x |
| Fair Price | 2.03 - 4.39 | 2.82 |
| Upside | -86.0% - -69.7% | -80.6% |
| Date | EV/EBITDA |
| 2025-06-27 | -93.79 |
| 2025-06-26 | -94.13 |
| 2025-06-25 | -97.79 |
| 2025-06-24 | -100.39 |
| 2025-06-23 | -96.57 |
| 2025-06-20 | -93.79 |
| 2025-06-19 | -94.83 |
| 2025-06-18 | -98.13 |
| 2025-06-17 | -99.35 |
| 2025-06-16 | -106.83 |
| 2025-06-13 | -108.91 |
| 2025-06-12 | -115.17 |
| 2025-06-11 | -114.30 |
| 2025-06-10 | -113.78 |
| 2025-06-09 | -115.35 |
| 2025-06-06 | -94.83 |
| 2025-06-05 | -84.57 |
| 2025-06-04 | -81.44 |
| 2025-06-03 | -82.49 |
| 2025-06-02 | -76.05 |
| 2025-05-30 | -79.18 |
| 2025-05-29 | -79.70 |
| 2025-05-28 | -77.97 |
| 2025-05-27 | -78.31 |
| 2025-05-26 | -72.05 |
| 2025-05-23 | -74.66 |
| 2025-05-22 | -69.97 |
| 2025-05-21 | -62.84 |
| 2025-05-20 | -58.32 |
| 2025-05-19 | -58.49 |
| 2025-05-16 | -56.41 |
| 2025-05-15 | -56.23 |
| 2025-05-14 | -59.36 |
| 2025-05-13 | -59.19 |
| 2025-05-12 | -59.71 |
| 2025-05-09 | -62.66 |
| 2025-05-08 | -64.40 |
| 2025-05-07 | -61.27 |
| 2025-05-06 | -64.23 |
| 2025-05-02 | -64.93 |
| 2025-04-30 | -62.66 |
| 2025-04-29 | -62.84 |
| 2025-04-28 | -64.58 |
| 2025-04-25 | -63.88 |
| 2025-04-24 | -65.10 |
| 2025-04-23 | -63.71 |
| 2025-04-22 | -61.97 |
| 2025-04-17 | -58.14 |
| 2025-04-16 | -58.67 |
| 2025-04-15 | -59.19 |